L-(+)-Cysteine → HCID 14881543, 화합물

HRID 129725

반응식

HRID 129725 반응식
[N:1]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[CH:4]=[C:3]([CH:11]=O)[CH:2]=1.[NH2:13][C@H:14]([C:17]([OH:19])=[O:18])[CH2:15][SH:16]>C(O)C>[N:1]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[CH:4]=[C:3]([CH:11]2[NH:13][CH:14]([C:17]([OH:19])=[O:18])[CH2:15][S:16]2)[CH:2]=1

참가 물질

4

반응물 2

HCID 5862L-(+)-CysteineHCID 836413-Quinolinecarboxaldehyde

생성물 1

HCID 14881543HCID 14881543, 화합물수율 75%

시약·촉매·용매 1

HCID 702Ethanol용매

실험 절차

Quinoline-3-carbaldehyde (1.57 g) and 1.21 g of L-cysteine were dissolved in 50 ml of 50% ethanol, and the solution was stirred at room temperature for 1 hour. The resultant crystalline precipitate was collected by suction filtrating, washed with 50% ethanol and dried to give 1.95 g of 2-(3-quinolyl)thiazolidine-4-carboxylic acid. Melting point 173°-175° C. (decomposition).

후처리

  1. customThe resultant crystalline precipitate was collected by suction
  2. filtrationfiltrating
  3. washwashed with 50% ethanol
  4. customdried

출처 및 근거

ORD 기록
ord-57fd1430ce8949a6a7d3214a55e2af97
출처 데이터셋
uspto-grants-1995_11
특허 번호
US05470851

연결된 노트

불러오는 중…